ISR Share Price

Open 0.60 Change Price %
High 0.66 1 Day 0.00 0.00
Low 0.60 1 Week 0.00 0.00
Close 0.63 1 Month 0.09 16.67
Volume 104682 1 Year -0.28 -30.77
52 Week High 1.30
52 Week Low 0.48
ISR Important Levels
Resistance 2 0.69
Resistance 1 0.66
Pivot 0.63
Support 1 0.60
Support 2 0.57
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
GBR 2.70 66.67%
GBR 2.70 66.67%
GBR 2.70 66.67%
RBY 0.03 -70.00%
RNN 0.51 13.33%
NGD 3.01 3.08%
NGD 3.01 3.08%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
GBR 2.70 66.67%
GBR 2.70 66.67%
GBR 2.70 66.67%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
INV 0.14 -17.65%
More..

IsoRay, Inc. (AMEX: ISR)

ISR Technical Analysis 2
As on 27th Mar 2017 ISR Share Price closed @ 0.63 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.72 & Buy for SHORT-TERM with Stoploss of 0.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
ISR Target for March
1st Target up-side 0.59
2nd Target up-side 0.63
3rd Target up-side 0.67
1st Target down-side 0.49
2nd Target down-side 0.45
3rd Target down-side 0.41
ISR Other Details
Segment EQ
Market Capital 20927304.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.isoray.com
ISR Address
ISR
350 Hills Street
Suite 106
Richland, WA 99354
United States
Phone: 509-375-1202
ISR Latest News
IsoRay Announces Final Court Approval of Class Action Settlement   PR Newswire (press release)   - 10th Mar 17
BRIEF-Isoray Inc's CFO Brien Ragle to resign   Reuters   - 17th Jan 17
IsoRay, Inc. Announces the Launch of a Pilot Study Using Intraoperative ...   PR Newswire (press release)   - 21st Dec 16
IsoRay Announces "Cesium-131 Brachytherapy for Salvage of Recurrent High Grade ...   PR Newswire (press release)   - 29th Nov 16
IsoRay, Inc. Announces Date for Fiscal 2017 Annual Meeting and Shareholder ...   PR Newswire (press release)   - 21st Oct 16
IsoRay Boosted By Brain Brachytherapy   Seeking Alpha   - 22nd Jun 16
IsoRay® Announces Results of Prospective Trial Presented at Society of Neuro ...   PR Newswire (press release)   - 21st Jun 16
IsoRay, Inc. Announces Annual Meeting and Shareholder Record Dates   PR Newswire (press release)   - 09th Apr 16
IsoRay Chairman and CEO Dwight Babcock to Retire   PR Newswire (press release)   - 07th Jan 16
IsoRay Could See Another Year Of Strong Gains   Seeking Alpha (registration)   - 04th Feb 15
Interactive Technical Analysis Chart IsoRay, Inc. ( ISR AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on IsoRay, Inc.
ISR Business Profile
IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, including primary and recurrent gliomas and metastic brain tumors. The company is based in Richland, Washington.